Form 4: Life360 Director Sells Shares Under 10b5-1 Plan

Life360 Director John Coghlan sold 3,125 shares of common stock for approximately $275,312 through a pre-arranged 10b5-1 trading plan.

Summary

• John Philip Coghlan, a Director of Life360, Inc. (LIF), reported the sale of common stock.
• A total of 3,125 shares were sold on September 2, 2025, under a Rule 10b5-1 trading plan.
• The sales consisted of two transactions: 508 shares at a weighted average price of $87.03 per share and 2,617 shares at a weighted average price of $88.33 per share.
• The total value of shares sold amounts to approximately $275,312.
• The Rule 10b5-1 trading plan was adopted by Mr. Coghlan on December 6, 2024, and is designed for automatic sales based on a predetermined formula, established when he was not aware of material nonpublic information.
• Following these transactions, Mr. Coghlan beneficially owns 3,344 direct shares (restricted stock units) and 76,979 indirect shares (9,375 shares held by the John Coghlan Living Trust and 67,604 shares held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust).

Sentiment

Score: 5

Explanation: The sentiment is neutral. While it's an insider sale, the execution under a pre-arranged 10b5-1 plan mitigates concerns that it's based on new negative information. It's likely for personal financial planning.

Positives

• The transaction was executed under a Rule 10b5-1 trading plan, which provides transparency and indicates the sale was pre-scheduled and not based on recent material nonpublic information.

Negatives

• The sale represents a reduction in direct insider holdings, which can sometimes be perceived negatively by the market, even if pre-planned.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

• The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 6, 2024.
• The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of Company stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.

Industry Context

This Form 4 filing reports an individual insider transaction and does not provide information directly related to broader industry trends or competitive landscape.

Corporate Governance

Related Party Transactions

• Shares are indirectly held by the John Coghlan Living Trust and The John Philip Coghlan 2025 Grantor Retained Annuity Trust, which are related entities to the reporting person.

Stakeholder Impact

• Shareholders may interpret insider sales differently; however, the 10b5-1 plan suggests the sale is for personal financial management rather than a reflection of company performance.
• The transparency provided by the 10b5-1 plan helps maintain investor confidence in the integrity of insider transactions.

Key Dates

Recommendation

The sale by Director John Coghlan was executed under a pre-arranged Rule 10b5-1 trading plan, indicating it was not based on new material nonpublic information. While it represents a reduction in insider holdings, such planned sales are common for diversification or liquidity purposes and do not inherently signal a negative outlook on the company's future performance. Investors should consider this a routine insider transaction rather than a fundamental shift in company prospects.

Keywords

Life360, LIF, Form 4, Insider Sale, John Coghlan, 10b5-1 Plan, Director, Stock Transaction